---
title: "BofA Securities Trims Price Target on Agios Pharmaceuticals to $54 From $55, Maintains Buy Rating"
date: "2025-02-11 22:50:42"
summary: "Agios Pharmaceuticals  has an average rating of overweight and mean price target of $57, according to analysts polled by FactSet."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Agios Pharmaceuticals has an average rating of overweight and mean price target of $57, according to analysts polled by FactSet.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250211:A3314578:0/)
